BDTX logo

Black Diamond Therapeutics, Inc.

BDTX
Healthcare|Biotechnology|US
$1.74
+0.07 (+4.52%)
DCF Value
$10.92
Tangible Book / Share
$1.68
Cash / Share
$1.93
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Nov 13, 2025 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Nov 2028
Est. completion
P2Glioblastoma (GBM)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Nov 2025
P1P2
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
NCT05256290

SEC Filings (37)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 16, 2026S-8Employee stock planDocumentIndex
Mar 16, 202610-KAnnual reportDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 3, 2025EFFECTDocumentIndex
Dec 3, 20258-KMaterial eventDocumentIndex
Nov 13, 2025S-3Shelf registrationDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex
Aug 7, 20258-KMaterial eventDocumentIndex
Jun 12, 20258-KMaterial eventDocumentIndex
May 12, 202510-QQuarterly reportDocumentIndex
May 12, 20258-KMaterial eventDocumentIndex
Apr 29, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Apr 18, 2025ARSAnnual report to holdersDocumentIndex
Apr 18, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 18, 2025DEF 14AProxy / shareholder voteDocumentIndex
Mar 21, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Mar 19, 20258-KMaterial eventDocumentIndex
Mar 6, 2025S-8Employee stock planDocumentIndex
Mar 6, 202510-KAnnual reportDocumentIndex
Mar 6, 20258-KMaterial eventDocumentIndex
Feb 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2024SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2024SC 13GPassive 5%+ stakeDocumentIndex